The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

Learn more about whether ICU Medical, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The VT Health Department, along with an Upper Valley nuring home is continuing to investigate the scoure of a Legionnaires’ outbreak.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...